-
The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly welcomes today's announcement by Luxembourg of a €11.7 million pledge for the upcoming three-year period, a 30% increase in Luxembourg’s contributions to the Global Fund from the previous...
-
Ahead of the Global Fund’s Seventh Replenishment Conference, the Global Fund and partners called on all players in the private sector – philanthropists, foundations, and corporations – for a step-change in their commitment to ending AIDS, tuberculosi...
-
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria thanks the European Union and Team Europe for their contribution to the Global Fund's COVID-19 Response Mechanism (C19RM). The President of the European Commission, Ursula von der Leyen, announc...
-
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria held its 47th Board meeting this week in Geneva. A few months ahead of the Global Fund’s Seventh Replenishment Conference to be hosted by the United States, the Board renewed its ca...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds the decision by New Zealand to contribute NZ$8 million to the Global Fund's COVID-19 Response Mechanism (C19RM). The new funding will help provide lifesaving diagnostic tests, treatment...
-
The Global Fund, the United States and Unitaid, together with FIND and other ACT-Accelerator partners, are launching over US$120 million in support to countries for test-and-treat programs to prevent hospitalizations and deaths from COVID-19 for thos...
-
Ahead of World Malaria Day, 25 April, the Global Fund calls for renewed commitment in the fight against malaria, a disease that now kills one child every minute. After years of steady declines, malaria cases and deaths are on the rise mainly due to s...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes President Joe Biden’s request to the United States Congress for a commitment of US$2 billion for the Global Fund for fiscal year 2023, the first year of the Global Fund...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria commends the announcement by Minister Svenja Schulze on the occasion of World Tuberculosis Day to make available an additional EUR175 million to the Global Fund's COVID-19 Response Mechanism, p...
-
On World TB Day, 24 March, the Global Fund is urgently calling for the world to reignite the fight to end tuberculosis (TB) by 2030.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria praises the decision by Canada to contribute CAD 60 million to the Global Fund's COVID-19 Response Mechanism (C19RM). The new funding will help provide lifesaving diagnostic tests, treatments – ...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$30 million to top up its Emergency Fund, including US$15 million to support the continuity of HIV and TB prevention, testing and treatment services in Ukraine.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds the decision by the United Kingdom Foreign, Commonwealth and Development Office to contribute GBP 60 million to the Global Fund's COVID-19 Response Mechanism.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the presidents of the Democratic Republic of the Congo, the Republic of Kenya, the Republic of Rwanda, the Republic of Senegal, and the Republic of South Africa launched the Global Fund’s Se...
-
The Global Fund praises Norway’s leadership in the global fight against COVID-19 after its decision to allocate NOK 440 million (US$49.1 million) to the Global Fund's COVID-19 Response Mechanism (C19RM). This new contribution, which is on top of the ...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds the decision by Luxembourg to contribute €2 million to the Global Fund's COVID-19 Response Mechanism.
-
Inequities have been widely acknowledged as barriers to achieving global and national goals and targets in HIV, TB and malaria programs. However, the magnitude and extent of underlying health inequalities have remained poorly documented and understoo...
-
The accuracy of existing molecular (PCR, NAAT) tests appears uncompromised by COVID-19 variant Omicron (B.1.1.529), designated a Variant of Concern by the World Health Organization (WHO) on Friday. Preliminary evidence suggests that this is also true...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes President Joe Biden's decision to host the Global Fund’s Seventh Replenishment Conference in the United States in the second half of 2022.